These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5514365)

  • 1. Further studies of the allergic nature of multiple sclerosis and the commencement of therapeutic trials.
    Campbell B; Vogel PJ; Fisher E; Lorenz R
    Trans Am Neurol Assoc; 1970; 95():192-5. PubMed ID: 5514365
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Immunologic mysteries of multiple sclerosis.
    Waksman BH
    N Engl J Med; 1974 Jul; 291(1):45-6. PubMed ID: 4832403
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 4. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
    Alvord EC
    Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelin peptides in multiple sclerosis.
    Grau-López L; Raïch D; Ramo-Tello C; Naranjo-Gómez M; Dàvalos A; Pujol-Borrell R; Borràs FE; Martínez-Cáceres E
    Autoimmun Rev; 2009 Jul; 8(8):650-3. PubMed ID: 19393199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental allergic encephalomyelitis and neuritis: immunologic responses to myelin basic proteins.
    Brostoff SW
    Birth Defects Orig Artic Ser; 1978; 14(5):245-60. PubMed ID: 687794
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prospects of an immunologic therapy of multiple sclerosis].
    Fasanaro G; Gentile A; Stella L
    Acta Neurol (Napoli); 1972; 27(4):367-78. PubMed ID: 5085161
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunology of multiple sclerosis.
    Kibler RF; Paty DW; Sherr V
    Res Publ Assoc Res Nerv Ment Dis; 1971; 49():95-111. PubMed ID: 5133707
    [No Abstract]   [Full Text] [Related]  

  • 9. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2).
    Paterson PY; Day ED
    Clin Immunol Rev; 1981-1982; 1(4):581-697. PubMed ID: 6188568
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on the pathogenic mechanisms of multiple sclerosis with a proposal for a therapeutic approach.
    Campbell B; Vogel PJ
    Trans Am Neurol Assoc; 1969; 94():234-6. PubMed ID: 4313960
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P; Raus J
    Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neuroglial and anti-neuronal cell factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Bornstein MB
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:574-607. PubMed ID: 4906733
    [No Abstract]   [Full Text] [Related]  

  • 14. The nature of factors in chronic relapsing EAE and MS sera which induce myelinotoxicity and cellular changes in organ culture.
    Bradbury K; Suckling AJ
    Prog Clin Biol Res; 1984; 146():193-8. PubMed ID: 6201890
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of experimental allergic encephalomyelitis to human disease.
    Levine S
    Res Publ Assoc Res Nerv Ment Dis; 1971; 49():33-49. PubMed ID: 5002492
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
    Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM; Alvord EC
    Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis.
    Petry KG; Boullerne AI; Pousset F; Brochet B; Caillé JM; Dousset V
    Pathol Biol (Paris); 2000 Feb; 48(1):47-53. PubMed ID: 10729911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathogenic mechanisms in experimental allergic encephalomyelitis.
    Kálmán B; Lublin FD
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):182-8. PubMed ID: 7683223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.